Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37,543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: Skin lesion morphology, clinical course, and scarring.
Prasad S, Galvan Casas C, Strahan AG, Fuller LC, Peebles K, Carugno A, Leslie KS, Harp JL, Pumnea T, McMahon DE, Rosenbach M, Lubov JE, Chen G, Fox LP, McMillen A, Lim HW, Stratigos AJ, Cronin TA, Kaufmann MD, Hruza GJ, French LE, Freeman EE. Prasad S, et al. Among authors: chen g. J Am Acad Dermatol. 2023 May;88(5):1066-1073. doi: 10.1016/j.jaad.2022.12.035. Epub 2023 Jan 11. J Am Acad Dermatol. 2023. PMID: 36641010 Free PMC article.
The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infections.
Freeman EE, Galvan Casas C, Prasad S, Fuller C, Peebles K, Rosenbach M, Fox L, McMahon DE, Strahan A, Lubov J, Chen G, Nguyen CV, McMillen A, Lim HW, Stratigos AJ, Kaufmann MD, Hruza GJ, French L. Freeman EE, et al. Among authors: chen g. J Am Acad Dermatol. 2022 Dec;87(6):1278-1280. doi: 10.1016/j.jaad.2022.08.053. Epub 2022 Sep 6. J Am Acad Dermatol. 2022. PMID: 36075281 Free PMC article.
HIV and mpox: Evaluation of clinical course and outcomes from an international dermatologic registry.
Strahan AG, Casas CG, Prasad S, Fuller LC, Peebles K, Carugno A, Leslie KS, Harp JL, Pumnea T, McMahon DE, Rosenbach M, Lubov JE, Chen G, Pacheco AM, Fox LP, McMillen A, Lim HW, Stratigos AJ, Cronin TA, Kaufmann MD, Hruza GJ, French LE, Freeman EE. Strahan AG, et al. Among authors: chen g. J Am Acad Dermatol. 2024 May;90(5):1011-1013. doi: 10.1016/j.jaad.2023.12.032. Epub 2023 Dec 27. J Am Acad Dermatol. 2024. PMID: 38157988 No abstract available.
The impact of COVID-19 vaccine reactions on secondary vaccine hesitancy.
Freeman EE, Strahan AG, Smith LR, Judd AD, Samarakoon U, Chen G, King AJ, Blumenthal KG. Freeman EE, et al. Among authors: chen g. Ann Allergy Asthma Immunol. 2024 May;132(5):630-636.e1. doi: 10.1016/j.anai.2024.01.009. Epub 2024 Jan 16. Ann Allergy Asthma Immunol. 2024. PMID: 38232816
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection.
Boucau J, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Lipiner T, Kittilson A, Melberg M, Li Y, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Goldberg MB, Vyas JM, Li JZ, Lemieux JE, Siedner MJ, Barczak AK. Boucau J, et al. Among authors: chen g. medRxiv [Preprint]. 2022 Mar 2:2022.03.01.22271582. doi: 10.1101/2022.03.01.22271582. medRxiv. 2022. Update in: N Engl J Med. 2022 Jul 21;387(3):275-277. doi: 10.1056/NEJMc2202092 PMID: 35262089 Free PMC article. Updated. Preprint.
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
Boucau J, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Lipiner T, Kittilson A, Melberg M, Li Y, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Goldberg MB, Vyas JM, Li JZ, Lemieux JE, Siedner MJ, Barczak AK. Boucau J, et al. Among authors: chen g. N Engl J Med. 2022 Jul 21;387(3):275-277. doi: 10.1056/NEJMc2202092. Epub 2022 Jun 29. N Engl J Med. 2022. PMID: 35767428 Free PMC article. No abstract available.
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).
Boucau J, Uddin R, Marino C, Regan J, Flynn JP, Choudhary MC, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Turbett SE, Li JZ, Lemieux JE, Barczak AK, Siedner MJ. Boucau J, et al. Among authors: chen g. Clin Infect Dis. 2023 Feb 8;76(3):e526-e529. doi: 10.1093/cid/ciac512. Clin Infect Dis. 2023. PMID: 35737946 Free PMC article.
37,543 results
You have reached the last available page of results. Please see the User Guide for more information.